An issue that keeps presenting with permitted indications is that a products indications should not be viewed in isolation but  should be viewed through the lens of the overall and complete product presentation for compliance. When a combination of indications are used, the complete presentation (including pictorials) needs to be assessed, and the question needs to be asked has the individual meaning been changed or does the complete picture now imply a disease or condition. The TGA has provided the following response as to why indications aren’t classified as ‘specific’ or ‘non specific’ within the Permitted Indications Determination.

Why aren’t the indications classified as ‘specific’ or ‘non-specific’ in the Determination?

The indicat